London, UK, 03-6-2014 — /EuropaWire/ — AstraZeneca today announced that the US Food and Drug Administration (FDA) has designated its novel investigational drug AZD0914 as a Qualified Infectious Disease Product (QIDP) and awarded its development programme Fast Track status for the treatment … Read the full press release
London, UK, 03-6-2014 — /EuropaWire/ — AstraZeneca provided an update on the rapid development of its oncology pipeline at a briefing for analysts and investors on 2 June 2014, as compelling data from over 40 scientific abstracts related to AstraZeneca and MedImmune … Read the full press release
For the first time scientists have been able to restore the ability to grasp with a paralysed hand using spinal cord stimulation. Newcastle, UK, 20-5-2014 — /EuropaWire/ — There is currently no cure for upper limb paralysis, where there has been damage … Read the full press release
Posted in Education, Healthcare, Science, Technology, United Kingdom
Tagged Dr Andrew Jackson, Dr John Williams, Dr Jonas Zimmermann, Frontiers in Neuroscience, Newcastle University, spinal cord stimulation, way to restore ability to grasp with paralysed hand using spinal cord stimulation, Wellcome Trust-funded
LEEDS, 20-5-2014 — /EuropaWire/ — A pioneering database at the University of Leeds will help match patients with certain types of blood cancers to the best treatments. The new resource, funded by the charity Leukaemia & Lymphoma Research, will store cancer … Read the full press release
Southampton, UK, 19-5-2014 — /EuropaWire/ — Doctors and scientists in Southampton have completed their first hip surgery with a 3D printed implant and bone stem cell graft. The 3D printed hip, made from titanium, was designed using the patient’s CT scan and … Read the full press release
Divestiture includes AngioJet (thrombectomy) and Jetstream (atherectomy) systems, and the Fetch2 Aspiration Catheter / Bayer HealthCare’s Medical Care division to focus on innovation and growth in Radiology and Diabetes Care business areas Leverkusen, Germany, 16-5-2014 — /EuropaWire/ — Bayer HealthCare has entered … Read the full press release
Genetically engineered antibodies are deployed successfully in cancer diagnostics and therapy. Therapeutic antibodies against Alzheimer’s disease and multiple sclerosis are currently under development. An important criterion when designing suitable antibody fragments is their stability. Comparing the antibodies of sharks, which … Read the full press release
Posted in Education, Germany, Healthcare, Science, Technology
Tagged Dr. Matthias J. Feige, Helmholtz Zentrum Muenchen, Johannes Buchner, Michael Groll, Michael Sattler, new approaches for stabilizing antibodies by comparing mammalian antibodies with those of sharks, professors Linda Hendershot, Technische Universitaet Muenchen
Dedicated mobile imaging solutions Equine DR 35 detector and CR 15-X digitizer will be available for competitors at all legs of the 2014 Tour Mortsel, Belgium, 15-5-2014 — /EuropaWire/ — Agfa HealthCare solutions will be used for X-ray screening of the … Read the full press release
On-the-go mobile medical image capture and secure management technology brings clinical relevance to the “medical selfie” Mortsel, Belgium/Greenville, SC, 15-5-2014 — /EuropaWire/ — New mobile and web capture technology extends Agfa HealthCare’s “gold standard” ICIS interoperable enterprise imaging platform to mobile … Read the full press release
Coventry, UK, 15-5-2014 — /EuropaWire/ — The role of being bullied in childhood on adult health has once more come under the spotlight, as new evidence shows a potential increased risk of cardiovascular and metabolic diseases for victims. C-Reactive Protein (CRP) levels … Read the full press release
Leicester, UK, 14-5-2014 — /EuropaWire/ — The University of Leicester Department of Genetics is to hold an open day on Saturday 7 June where the technological impact of modern life on our natural body clock will be discussed. Today is the BBC’s Day … Read the full press release
New hospital site for Karolinska in Solna, Sweden will have access to state-of-the art imaging solutions and services for a 14-year term at predictable costs Agreement includes research and innovation collaboration that unites researchers from industry, hospital and academia Solna, … Read the full press release
When emotions are processed in a negatively biased manner in the brain, an individual is at risk to develop depression. Psilocybin, the bioactive component of the Mexican magic mushroom, seems to intervene positively in the emotion-processing mechanism. Even a small … Read the full press release
Trinity researchers say new data points to need for introduction of universal HPV vaccination for boys as well as girls. DUBLIN, 7-5-2014 — /EuropaWire/ — A new study by researchers in the School of Medicine, Trinity College Dublin, has revealed a high … Read the full press release
• Darmstadt-based company holds global rights to the name Merck with exception of the U.S. and Canada Darmstadt, Germany, 7-5-2014 — /EuropaWire/ — Merck, the supplier of top-quality high-tech products in the pharmaceuticals and chemicals sectors, today clarified that it will … Read the full press release
Posted in Business, Healthcare, Management, Pharma & Biotech
Tagged Gangolf Schrimpf, Merck, pharmaceuticals and chemicals sectors
Shan5™ is the first vaccine jointly developed by the Indian company and its parent company Sanofi Pasteur WHO’s decision allows for the purchase of Shan5™ by United Nations agencies Lyon, France, 7-5-2014 — /EuropaWire/ — Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: … Read the full press release
Frankfurt / Berlin, Germany and Nevada, USA, 5-5-2014 — /EuropaWire/ — Nanostart-holding MagForce, a leading medical device company in the field of nanomedicine focused on oncology, together with its subsidiary MagForce USA, Inc. are pleased to report that an in-person meeting was … Read the full press release
London, 29-4-2014 — /EuropaWire/ — GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) today announced the start of a phase III global programme to evaluate the efficacy and safety of tafenoquine, an investigational medicine which is being developed for the treatment and … Read the full press release
London, 29-4-2014 — /EuropaWire/ — GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the European Commission has granted marketing authorisation for Incruse® (umeclidinium) as a once-daily, maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). Now licensed across … Read the full press release
Posted in Business, European Union, Healthcare, Marketing, Pharma & Biotech, United Kingdom
Tagged Chronic obstructive pulmonary disease, Darrell Baker, GlaxoSmithKline, GlaxoSmithKline's Incruse® (umeclidinium) gets European Commission marketing authorisation, Incruse® (umeclidinium), maintenance bronchodilator treatment of COPD
Expanded indication makes cobas HPV Test the only test approved in U.S. that can be used instead of Pap in first-line primary screening in women 25 and older Basel, 29-4-2014 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?